Impairment of contextual fear conditioning in rats by Group I mGluRs: reversal by the nootropic nefiracetam

Gernot Riedel, K. Sandager-Nielsen, E. M. Macphail

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The blockade of Group I metabotropic glutamate receptors (mGluRs) may be a potential strategy for prevention therapy of neurotoxicity. We here confirm previous reports that systemic application of the Group I antagonist, 1-aminoindan-1,5-dicarboxylic acid (AIDA), causes amnesia in a contextual fear conditioning paradigm in rats. This deficit was fully reversed by long-term pretreatment with the nootropic nefiracetam, which in fact obtained supranormal performance. Our data suggest that application of Group I antagonists to prevent neurotoxicity, combined with nootropic treatment to prevent cognitive deficits, may be a therapeutic strategy for the development of novel antineurotoxic treatments. (C) 2002 Elsevier Science Inc. All rights reserved.

Original languageEnglish
Pages (from-to)391-399
Number of pages8
JournalPharmacology, Biochemistry & Behavior
Volume73
Issue number2
DOIs
Publication statusPublished - 2002

Keywords

  • metabotropic glutamate receptors (mGluRs)
  • nootropic
  • fear conditioning
  • memory
  • rat
  • METABOTROPIC GLUTAMATE RECEPTORS
  • LONG-TERM-POTENTIATION
  • COGNITION-ENHANCING AGENT
  • ANTAGONIST 1-AMINOINDAN-1,5-DICARBOXYLIC ACID
  • NICOTINIC ACETYLCHOLINE-RECEPTORS
  • WORKING-MEMORY
  • OLDER RABBITS
  • HIPPOCAMPAL NEUROTRANSMISSION
  • NEUROPROTECTIVE ACTIVITY
  • CORTICAL-NEURONS

Cite this

Impairment of contextual fear conditioning in rats by Group I mGluRs: reversal by the nootropic nefiracetam. / Riedel, Gernot; Sandager-Nielsen, K.; Macphail, E. M.

In: Pharmacology, Biochemistry & Behavior, Vol. 73, No. 2, 2002, p. 391-399.

Research output: Contribution to journalArticle

@article{7fd42606bdbd49849aa738c59c0542fb,
title = "Impairment of contextual fear conditioning in rats by Group I mGluRs: reversal by the nootropic nefiracetam",
abstract = "The blockade of Group I metabotropic glutamate receptors (mGluRs) may be a potential strategy for prevention therapy of neurotoxicity. We here confirm previous reports that systemic application of the Group I antagonist, 1-aminoindan-1,5-dicarboxylic acid (AIDA), causes amnesia in a contextual fear conditioning paradigm in rats. This deficit was fully reversed by long-term pretreatment with the nootropic nefiracetam, which in fact obtained supranormal performance. Our data suggest that application of Group I antagonists to prevent neurotoxicity, combined with nootropic treatment to prevent cognitive deficits, may be a therapeutic strategy for the development of novel antineurotoxic treatments. (C) 2002 Elsevier Science Inc. All rights reserved.",
keywords = "metabotropic glutamate receptors (mGluRs), nootropic, fear conditioning, memory, rat, METABOTROPIC GLUTAMATE RECEPTORS, LONG-TERM-POTENTIATION, COGNITION-ENHANCING AGENT, ANTAGONIST 1-AMINOINDAN-1,5-DICARBOXYLIC ACID, NICOTINIC ACETYLCHOLINE-RECEPTORS, WORKING-MEMORY, OLDER RABBITS, HIPPOCAMPAL NEUROTRANSMISSION, NEUROPROTECTIVE ACTIVITY, CORTICAL-NEURONS",
author = "Gernot Riedel and K. Sandager-Nielsen and Macphail, {E. M.}",
year = "2002",
doi = "10.1016/S0091-3057(02)00830-4",
language = "English",
volume = "73",
pages = "391--399",
journal = "Pharmacology, Biochemistry & Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Impairment of contextual fear conditioning in rats by Group I mGluRs: reversal by the nootropic nefiracetam

AU - Riedel, Gernot

AU - Sandager-Nielsen, K.

AU - Macphail, E. M.

PY - 2002

Y1 - 2002

N2 - The blockade of Group I metabotropic glutamate receptors (mGluRs) may be a potential strategy for prevention therapy of neurotoxicity. We here confirm previous reports that systemic application of the Group I antagonist, 1-aminoindan-1,5-dicarboxylic acid (AIDA), causes amnesia in a contextual fear conditioning paradigm in rats. This deficit was fully reversed by long-term pretreatment with the nootropic nefiracetam, which in fact obtained supranormal performance. Our data suggest that application of Group I antagonists to prevent neurotoxicity, combined with nootropic treatment to prevent cognitive deficits, may be a therapeutic strategy for the development of novel antineurotoxic treatments. (C) 2002 Elsevier Science Inc. All rights reserved.

AB - The blockade of Group I metabotropic glutamate receptors (mGluRs) may be a potential strategy for prevention therapy of neurotoxicity. We here confirm previous reports that systemic application of the Group I antagonist, 1-aminoindan-1,5-dicarboxylic acid (AIDA), causes amnesia in a contextual fear conditioning paradigm in rats. This deficit was fully reversed by long-term pretreatment with the nootropic nefiracetam, which in fact obtained supranormal performance. Our data suggest that application of Group I antagonists to prevent neurotoxicity, combined with nootropic treatment to prevent cognitive deficits, may be a therapeutic strategy for the development of novel antineurotoxic treatments. (C) 2002 Elsevier Science Inc. All rights reserved.

KW - metabotropic glutamate receptors (mGluRs)

KW - nootropic

KW - fear conditioning

KW - memory

KW - rat

KW - METABOTROPIC GLUTAMATE RECEPTORS

KW - LONG-TERM-POTENTIATION

KW - COGNITION-ENHANCING AGENT

KW - ANTAGONIST 1-AMINOINDAN-1,5-DICARBOXYLIC ACID

KW - NICOTINIC ACETYLCHOLINE-RECEPTORS

KW - WORKING-MEMORY

KW - OLDER RABBITS

KW - HIPPOCAMPAL NEUROTRANSMISSION

KW - NEUROPROTECTIVE ACTIVITY

KW - CORTICAL-NEURONS

U2 - 10.1016/S0091-3057(02)00830-4

DO - 10.1016/S0091-3057(02)00830-4

M3 - Article

VL - 73

SP - 391

EP - 399

JO - Pharmacology, Biochemistry & Behavior

JF - Pharmacology, Biochemistry & Behavior

SN - 0091-3057

IS - 2

ER -